Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
CAS NO.: 307297-39-8
Raun et al., Ipamorelin, the first selective growth hormone secretagogue, Endocrinology, November 1998
Heres what WORKS based on decades of clinical evidence and real-world outcomes: Therapeutic testosterone replacement therapy (TRT) when indicated, dosed properly, and with appropriate monitoring and estrogen management
Keep reading to learn more, navigate to the FAQ below and visit the Quarterly Drug Pipeline for more clinical insights on anticipated drugs in development
The pathogenesis of sarcopenia is complex and multifaceted: the chronic catabolic condition, increased energy expenditure, reduced appetite, side effects of multiple therapies, alterations in circulating levels of hormones, low protein synthesis, and the presence of ascites or portosystemic shunts are all factors contributing to muscle atrophy in cirrhotic patients [23]
[14] It was initially known as BIM-22493 and then as RM-493 and IRC-022493
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
